Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis
Crossref DOI link: https://doi.org/10.1007/s00228-017-2217-3
Published Online: 2017-03-10
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dymond, Angela W.
Elks, Cathy
Martin, Paul
Carlile, David J.
Mariani, Gabriella
Lovick, Susan
Huang, Yifan
Lorch, Ulrike
Brown, Helen
So, Karen
Funding for this research was provided by:
AstraZeneca
License valid from 2017-03-10